RJN-18630-97055 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-10-24
Dose 1 — Pfizer-BioNTech
Co-administered: Hepatitis B:Hib:Other:Polio:Tetanus
2022-11-29
Dose 2 — Pfizer-BioNTech
Co-administered: Other
2022-12-26
Registered in v-safe
2022-12-26
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-12-27
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-01-03
Health check-in — day 35, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-01-10
Survey response — day 42, dose 2, under 3
MedDRA: Cough, Sneezing — Feeling: Fair

MedDRA releases: 2024-11
2023-03-01
Health check-in — 3 months, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-05-30
Health check-in — 6 months, dose 2, under 3
Feeling: Fair

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-10-24	Pfizer-BioNTech	Hepatitis B:Hib:Other:Polio:Tetanus
2	2022-11-29	Pfizer-BioNTech	Other

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Sneezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release